Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Clinical Evaluation
100%
Human Papillomavirus Testing
100%
Colposcopy
100%
GeneXpert
100%
Xpert
100%
High-risk Human Papillomavirus (HR-HPV)
66%
Cobas
66%
Hybrid Capture
50%
Positive Predictive Value
33%
HPV16
33%
Batch Test
33%
Cervical Cancer
33%
Same-day
16%
United States
16%
Molecular Systems
16%
Screening Test
16%
Histologic
16%
Clinical Performance
16%
Human Papillomavirus Types
16%
U.S. Food
16%
Improved Detection
16%
Qiagen
16%
Primary Screening
16%
Cervical Intraepithelial Neoplasia Grade 3
16%
Point-of-care Testing
16%
Random Access
16%
Access Platform
16%
Molecular Hybrids
16%
Colposcopy Referral
16%
Cobas HPV Test
16%
High-risk Human Papillomavirus Testing
16%
Management Strategies
16%
Clinical Site
16%
Nursing and Health Professions
Clinical Evaluation
100%
Colposcopy
100%
Human Papillomavirus DNA Test
100%
Clinical Trial
100%
Polymerase Chain Reaction System
100%
Predictive Value
50%
Uterine Cervix Carcinoma in Situ
50%
Malignant Neoplasm
25%
Screening Test
25%
Patient Referral
25%
Food and Drug Administration
25%
Hexachlorophene
25%
Precancer
25%
Point of Care Testing
25%
Medicine and Dentistry
Clinical Trial
100%
Wart Virus
100%
Colposcopy
100%
Human Papillomavirus Type 16
33%
Cervical Intraepithelial Neoplasia
33%
Malignant Neoplasm
16%
Screening Test
16%
Precancerous Condition
16%
Patient Referral
16%
Point-of-Care Testing
16%
Hexachlorophene
16%